Senseonics has signed a memorandum of understanding (MoU) with Ascensia Diabetes Care to take over the distribution of Eversense continuous glucose monitoring (CGM) systems.
Upon signing a definitive agreement, Senseonics will assume control of the global sales and marketing of Eversense CGM in January 2026.
Ascensia Diabetes Care, a subsidiary of PHC Group, acquired the rights to distribute Eversense in 2020 and launched the only one-year CGM system, Eversense 365.
The parties are currently working together to develop definitive documentation for the planned transaction.
PHC Group chief operating officer and chief strategy officer and Ascensia Diabetes Care CEO Koichiro Sato said: “We are very proud to have worked with Senseonics on commercialising Eversense and are committed to supporting Senseonics in establishing their own commercial operations and smoothly transitioning to them under the planned agreements.
“The Eversense long-term CGM system can help overcome many frustrations in diabetes management, and we believe in the growth potential of Eversense and remain invested in Senseonics.”
According to PHC, Eversense has diverged from Ascensia Diabetes Care’s core business, and the shift to Senseonics will promote the development, manufacturing, and distribution.
Upon signing a definitive agreement, most of Ascensia Diabetes Care’s Eversense team is expected to be transitioned to Senseonics.
Ascensia Diabetes Care CGM president Brian Hansen will be appointed as Senseonics’ chief commercial officer.
Furthermore, Senseonics aims to better address stakeholder needs, improve margins, and increase revenue through a $100m debt facility from Hercules Capital.
Senseonics president and CEO Tim Goodnow said: “I’m thrilled to bring Eversense 365 commercialisation back in-house and directly control investment in growing the brand to better serve the needs of patients and providers.
“With Brian to remain at the helm of Senseonics’ commercialisation efforts, we are confident that this move will yield benefits for our customers and our shareholders.
“We look forward to welcoming the talented commercial team to Senseonics to help ensure a positive experience for our customers, while working to accelerate the growth of Eversense 365.”
